Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion type Assertion NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_head.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion description "[Smoking (OR, 2.48; 95?% CI, 1.20-5.15), the A1691 mutation in factor V gene (OR, 3.64; 95?% CI, 1.31-10.10), and the A20210 mutation in the prothrombin gene (OR, 8.40; 95?% CI 3.35-21.05) were associated with FH of premature stroke (n = 33), while circulating anti-phospholipids to FH of premature myocardial infarction (n = 45; OR, 3.48; 95?% CI, 1.61-7.51).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_provenance.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion evidence source_evidence_literature NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_provenance.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion SIO_000772 25413729 NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_provenance.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion wasDerivedFrom befree-2016 NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_provenance.
- NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_assertion wasGeneratedBy ECO_0000203 NP1239002.RA2c5VgMqo-SLdux3YHktDGYQ5U-MpihzfbPByIvq6Jx0130_provenance.